Want to join the conversation?
$MKC reported stronger earnings in 3Q16, helped by higher operating income, including the impact of special charges, as well as a favorable tax rate and lower shares outstanding, compared to 3Q15. Net income was $127.7MM or $1.00 per diluted share versus $97.6MM or $0.76 per diluted share last year. Net sales grew 3% from last year to $1.09Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?